Unia Europejska - duński - EMA (European Medicines Agency)

zambon spa - safinamid methansulfonat - parkinsons sygdom - anti-parkinson-lægemidler - xadago er indiceret til behandling af voksne patienter med idiopatisk parkinsons sygdom (pd) som tilføjelse terapi til en stabil dosis af levodopa (l-dopa) alene eller i kombination med andre pd lægemidler i midt-til sene svingende patienter.

Unia Europejska - duński - EMA (European Medicines Agency)

eli lilly nederland b.v. - baricitinib - arthritis, reumatoid - immunosuppressiva - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumiant kan anvendes som monoterapi eller i kombination med methotrexat. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.

Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

reckitt benckiser healthcare (scandinavia) a/s - flurbiprofen - sugetabletter - 8,75 mg

Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

reckitt benckiser healthcare (scandinavia) a/s - flurbiprofen - sugetabletter - 8,75 mg

Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 generics aps - etoricoxib - filmovertrukne tabletter - 120 mg

Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 generics aps - etoricoxib - filmovertrukne tabletter - 30 mg

Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 generics aps - etoricoxib - filmovertrukne tabletter - 60 mg

Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 generics aps - etoricoxib - filmovertrukne tabletter - 90 mg

Unia Europejska - duński - EMA (European Medicines Agency)

novartis europharm ltd. - nateglinid - diabetes mellitus, type 2 - narkotika anvendt i diabetes - nateglinid er indiceret til kombinationsbehandling med metformin hos type 2 diabetespatienter utilstrækkeligt kontrolleret trods en maksimalt tolereret dosis af metformin alene.

Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - celecoxib - kapsler, hårde - 200 mg